What do patients want from healthcare? Professor David Haslam CBE Chair, NICE
DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know...
Transcript of DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know...
![Page 1: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/1.jpg)
DocSpot – what patients
want to know
Professor Chris Denton
Royal Free Hospital
London, UK
Madrid, February 2012
![Page 2: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/2.jpg)
Copyright © 2011 Raynaud's & Scleroderma Association.Charity Reg. No. 326306
![Page 3: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/3.jpg)
DocSpot Live!DocSpot Live!
Chris DentonChris DentonRoyal Free HospitalRoyal Free Hospital
![Page 4: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/4.jpg)
DocSpot Live!DocSpot Live!
Chris DentonChris DentonRoyal Free HospitalRoyal Free Hospital
![Page 5: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/5.jpg)
I have been diagnosed with scleroderma and the biggest problem I have is with itching –
why is this and what can be done?
![Page 6: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/6.jpg)
I have been diagnosed with scleroderma and the biggest problem I have is with itching –
why is this and what can be done?
• Itching of the skin (pruritis) is common – especially in dcSSc– Tends to occur in early disease– Due to mast cell degranulation and inflammatory cells and
mediators
• Almost always gets better when the skin score falls –improvement is a sign that disease is stabilising
• Other medical causes:– Skin disease – eczema, dermatitis herpetiformis (coeliac
disease)– Iron deficiency, thyroid disease– Liver or kidney problems (PBC)
![Page 7: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/7.jpg)
Natural history of itching in scleroderma
1 2 3 years
• intensity
Duration of disease
In diffuse SSc itching is a sign of activity
![Page 8: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/8.jpg)
Management of itching in scleroderma• Determine any other medical cause
• Skin care– emolients/moisturisers/counter-irritants
• Medication– antihistamines (drowsiness)– corticosteroids– low dose oral prednisolone (topical
disappointing) – mast cell stabilisation – ketotifen – disappointing results– Leukotriene inhibitors – montelukast – anecdotal benefit
• Treat the underlying disease– immunosuppression – MTX, MMF etc ...– topical MMF– topical tacrolimus
![Page 9: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/9.jpg)
I have Raynaud’s and feel tired all the time and wonder if there is a link between Raynaud’s phenomenon and chronic
fatigue syndrome?
![Page 10: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/10.jpg)
I have Raynaud’s and feel tired all the time and wonder if there is a link between Raynaud’s phenomenon and chronic
fatigue syndrome?
• There is no direct link• However any chronic health problem can affect general
wellbeing.• Some associated CTD may cause profound fatigue
(SLE, SSc, SS)
Consider the Raynaud’s• Definition of the type of RP• Try to minimise the impact of Raynaud’s on lifestyle
– Education, drugs, supplements ….
![Page 11: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/11.jpg)
Treatment of fatigue …
Medical approach:• General medical assessment –
– e.g. thyroid disease (in 30% of SSc)– anaemia etc…– SSc– depression
• Treatment of underlying connective tissue disease if present (e.g. hydroxychloroquine, azathioprine, low dose prednisolone)
• In SLE graded exercise programmes have shown promise in clinical trials
![Page 12: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/12.jpg)
I have hard lumps of “chalk” under my skin and have CREST – what
does this mean?
![Page 13: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/13.jpg)
CREST• Calcinosis• Rayaud’s• oEsophageal dysmotility• Sclerodactyly• Telangiectasia
![Page 14: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/14.jpg)
Major clinical subsets of systemic sclerosisLimited cutaneous SSc Diffuse cutaneous SSc
![Page 15: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/15.jpg)
Calcinosis
![Page 16: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/16.jpg)
![Page 17: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/17.jpg)
![Page 18: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/18.jpg)
Mechanism of calcinosis in scleroderma
• Calcinosis– deposition of calcium containing salts in soft
connective tissue - calcium hydroxyapetite– NOT just in CREST – also late stage dcSSc
• Cause:• Trauma• Poor blood supply• Altered extracellular matrix• Genetics • Abnormal metabolism - TGFβ1 and BMPs
– Research ongoing (Ariane Herrick, Hope Hospital)
?
![Page 19: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/19.jpg)
Treatment of calcinosis
• Simple approaches:– Wax massage– avoid interference– Treat secondary infection
• Surgical excision– open surgery– dental drill extraction– (Lithotripsy – sound shock waves)
• Medical therapy – none proven– optimise Raynaud’s therapy– Diltiazem? Warfarin?– Bisphosphonates– Minocycline– Anti-TNFα and methotrexate in
severe cases?
![Page 20: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/20.jpg)
The opposite of calcinosis – acro-osteolysis
![Page 21: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/21.jpg)
My sister has rheumatoid arthritis – is there any association with me having
scleroderma?
![Page 22: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/22.jpg)
Overlap syndromes
Systemic sclerosis (SSc) is associated with clinical and serological features of another connective tissue disease (inflammatory arthritis, myositis, Sjögren’s syndrome, lupus).
SScmyositis arthritis
lupus Sjögrens
![Page 23: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/23.jpg)
RA-scleroderma overlap syndrome
• RF positive
• arthritis - may be erosive
• scleroderma - ANA positive
• often SSc-specific serology
![Page 24: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/24.jpg)
Extensor digitorum tenosynovitis
Power doppler USS hands
![Page 25: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/25.jpg)
Frequency of overlap SSc in the Royal Free Hospital scleroderma cohort
All SSc 1700Limited SSc 967 (57%)
Diffuse SSc 394 (23%)SSc overlap syndrome 339 (20%)
n =
Overlap features were equally distributed between diffuse and limited subset
Pakozdi et al, J Rheum 2011; 38:2406-09
![Page 26: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/26.jpg)
Distribution of patients with SSc overlap syndromes
All overlap SSc 339 (100%)
SSc/myositis 128 (37%)SSc/inflammatory arthritis 95 (28%)SSc/Sjögren syndrome 52 (15%)SSc/lupus 27 (8%)
≥ 3 CTD 37 (12%)
Pakozdi et al, J Rheum 2011; 38:2406-09
![Page 27: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/27.jpg)
Management of systemic sclerosis
dcSSclcSSc
Manage according
to severity and
activity of overlap
features – arthritis,
myositis, lupus
Therapy:
Vascular
Identification and
treatment of organ-
based complications
Therapy:
Vascular
Immunosuppressive
Antifibrotic
SYSTEMIC SCLEROSIS
Overlap SSc
Pakozdi et al J Rheum 2011
Overlap features 332 of 1700
(20%) SSc cases
Myositis 43%
Arthritis 32%
Sjogren’s 17%
SLE 8%
![Page 28: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/28.jpg)
Why do I have so much pain in my hands?
![Page 29: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/29.jpg)
Causes for musculoskeletal pain in
systemic sclerosis
• Contractural arthropathy
• Contractural tendinopathy
• Arthritis
• Myositis
• Fasciitis
• Connective tissue atrophy
• Calcinosis
• Neuropathic pain
• Ischaemic digital vasculopathy
Sclerotic
Inflammatory
Dystrophic
Neurovascular
![Page 30: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/30.jpg)
Common musculoskeletal manifestations of
systemic sclerosis
tendinitis
arthritis
Rheumatoid arthritis overlap
![Page 31: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/31.jpg)
Other causes for musculoskeletal pain in systemic sclerois
Massive calcific
periarthritisGangrene associated with macrovascular occlusion
![Page 32: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/32.jpg)
Therapy for upper limb pain in scleroderma
• Pain killers• Physical therapy• Disease modifying drugs for arthritis (DMARDs)• SSc management• Multidisciplinary management
– Pain– Vascular specialists– Nurses– Psychologist– Physician– Surgeon– Physiotherapist– Occupational therapist
![Page 33: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/33.jpg)
I have scleroderma and cannot get out of a chair unaided – why?
![Page 34: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/34.jpg)
SSc/myositis overlap
• The prevalence of the diffuse subset in SSc/myositis overlap is relatively high (40%) compared to other SSc overlap syndromes (17-26%).
• PM-Scl is the main autoantigen in patients with SSc/myositis overlap syndrome
• nRNP and U3RNP also associated frequently found in SSc/myositis overlap
![Page 35: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/35.jpg)
Anti-nRNP
Anti-PM-Scl
Anti-Fibrillarin
Scleroderma hallmark
autoantibodies
associated with overlap
myositis
![Page 36: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/36.jpg)
MRI Lumbar spine – back pain and weakness
T2W image
![Page 37: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/37.jpg)
Why am I taking drugs for arthritis when I have been diagnosed with
scleroderma?
![Page 38: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/38.jpg)
Immunosuppressive therapy for dcSSc
Early stage dcSSc Late stage dcSSc
Potential immunomodulatory strategiesMethotrexateCyclophosphamideAzathioprineMycophenolate mofetilAnti-thymocyte globulinCiclosporin, Tacrolimus, Basiliximab, RituximabRapamycinStem cell transplant (autologous/allogeneic)Oral tolerance to type I collagen
![Page 39: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/39.jpg)
0
10
20
30
40
50
0
10
20
30
40
50
BaselineYear1 Year2 Year3 BaselineYear1 Year2 Year3 BaselineYear1 Year2 Year3
BaselineYear1 Year2 Year3 BaselineYear1 Year2 Year3
Cyclo then MMF ATG then MMF MMF
No active therapy Other (MTX etc)mR
SS
Skin score over time, by treatment protocol
Skin score change in UK observational study 0f dcSSc
Herrick et al, J Rheum (2010); 37: 116-24.
Herrick et al, J Rheum (2010); 37: 116-24.
147 patients from 12 centres– No difference between protocols
– Intention to treat analysis
– Deterioration usually led to
intensified therapy
ESOS – EULAR-ODP funded– MTX, cyclophosphamide, MMF ~400
subjects
![Page 40: DocSpot–what patients want to know - Esclerodermia · DocSpot–what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012](https://reader030.fdocuments.us/reader030/viewer/2022020317/5bc36d3709d3f27a338bb44f/html5/thumbnails/40.jpg)
Any more questions?